Literature DB >> 11832370

Abdominal adiposity and insulin resistance in obese men.

Robert Ross1, James Aru, Jennifer Freeman, Robert Hudson, Ian Janssen.   

Abstract

We examined the independent relationships among various visceral and abdominal subcutaneous adipose tissue (AT) depots, glucose tolerance, and insulin sensitivity in 89 obese men. Measurements included an oral glucose tolerance test (OGTT), glucose disposal by euglycemic clamp, and abdominal and nonabdominal (e.g., peripheral) AT by magnetic resonance imaging (MRI). OGTT glucose and glucose disposal rates were related (P < 0.05) to visceral AT (r = 0.50 and -0.41, respectively). These observations remained significant (P < 0.05) after control for nonabdominal and abdominal subcutaneous AT, and maximal O(2) consumption (VO(2 max)). Abdominal subcutaneous AT was not a significant correlate (P > 0.05) of any metabolic variable after control for nonabdominal and visceral AT and VO(2 max). Division of abdominal subcutaneous AT into deep and superficial depots and visceral AT into intra- and extraperitoneal AT depots did not alter the observed relationships. Further analysis matched two groups of men for abdominal subcutaneous AT but also for low and high visceral AT. Men with high visceral AT had higher OGTT glucose values and lower glucose disposal rates compared with those with low visceral AT values (P < 0.05). A similar analysis performed on two groups of men matched for visceral AT but also for high and low abdominal subcutaneous AT revealed no statistically different values for any metabolic variable (P > 0.10). In conclusion, visceral AT alone is a strong correlate of insulin resistance independent of nonabdominal and abdominal subcutaneous AT and cardiovascular fitness. Subdivision of visceral and abdominal subcutaneous AT by MRI did not provide additional insight into the relationship between abdominal obesity and metabolic risk in obese men.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832370     DOI: 10.1152/ajpendo.00469.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  71 in total

1.  Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.

Authors:  Alexis Cutchins; Daniel B Harmon; Jennifer L Kirby; Amanda C Doran; Stephanie N Oldham; Marcus Skaflen; Alexander L Klibanov; Nahum Meller; Susanna R Keller; James Garmey; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 2.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Authors:  Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

4.  Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat.

Authors:  Valerie B O'Leary; Christine M Marchetti; Raj K Krishnan; Bradley P Stetzer; Frank Gonzalez; John P Kirwan
Journal:  J Appl Physiol (1985)       Date:  2005-12-22

5.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

Review 6.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

7.  Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.

Authors:  Lynae J Hanks; Rikki M Tanner; Paul Muntner; Holly Kramer; William M McClellan; David G Warnock; Suzanne E Judd; Orlando M Gutiérrez
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

Review 8.  Abdominal obesity: the cholesterol of the 21st century?

Authors:  Jean-Pierre Després; Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 9.  Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction?

Authors:  Robert Ross; Peter M Janiszewski
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

10.  Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats.

Authors:  Hisayo Morinaga; Takeshi Ohta; Kenichi Matsui; Tomohiko Sasase; Sumiaki Fukuda; Makoto Ito; Masatoshi Ueda; Yukihito Ishii; Katsuhiro Miyajima; Mutsuyoshi Matsushita
Journal:  Exp Diabetes Res       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.